January 2010 – Page 2

Newswire

[ September 10, 2025 ] Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus Newsmakers
[ September 10, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities Newsmakers
[ September 10, 2025 ] Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early Newsmakers
[ September 4, 2025 ] Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ]. Newsmakers
[ September 4, 2025 ] Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards Newsmakers
[ August 28, 2025 ] Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030 Newsmakers
[ August 27, 2025 ] Advent Technologies (NASDAQ: ADN) engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets Newsmakers
[ August 27, 2025 ] Wellgistics Health (NASDAQ: WGRX) Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem Healthcare
[ August 26, 2025 ] Advent (NASDAQ: ADN) Technologies Pursuing Trailblazing Initiatives in Space Aerospace & Defense
[ August 21, 2025 ] Advent Technologies (NASDAQ: ADN) and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing Advent Technologies Holdings, Inc. Thu, August 21, 2025 at 5:00 AM PDT 4 min read Aviation

GlobalSCAPE (NYSE AMEX: GSB) CEO Interview

January 22, 2010 Jack Comments Off

GlobalSCAPE (NYSE AMEX: GSB) Interview with Jim Morris, CEO & President […]

Intra Op Medical (OTC BB: IOPD) CEO Interview

January 22, 2010 Jack Comments Off

Intra Op Medical (OTC BB: IOPD) Interview with John Powers, CEO […]

Nemaska Exploration (TSX.V:NMX) CEO Interview

January 22, 2010 Jack Comments Off

Nemaska Exploration (TSX.V:NMX) Interview with Guy Bourass, CEO […]

International PBX Ventures Acquires Copper/Molybdenum Mineral Claims in Chile

January 22, 2010 Jack Comments Off

Acquires Claims West of Its Copaquire Copper-Molybdenum-Rhenium Project […]

International PBX Ventures Ltd (TSX.V: PBX) CEO Interview

January 22, 2010 Jack Comments Off

International PBX Ventures Ltd (TSX.V: PBX) Interview with George Sookochof, CEO […]

Marc Faber “Sell Your Stocks and Get Drunk in 2010”

January 20, 2010 Jack Comments Off

Marc Faber says S&P 500 likely to drop in 2010; years ending in “0” and mid-term election years generally are negative for stocks. […]

How to Profit From the “Double Dip” Recession

January 18, 2010 Jack Comments Off

Shorting consumer and bank stocks as “recovery” runs out of steam […]

2010 is “Year of Reckoning” According to Pimco’s Bill Gross

January 17, 2010 Jack Comments Off

Bond Guru Bill Gross, says growth slows in second half of 2010, rates will rise. […]

Sitebrand, Inc (TSX.V: SIB) CEO Interview

January 15, 2010 Jack Comments Off

Sitebrand, Inc (TSX.V: SIB) Interview with Chris Corman, President & CEO
[…]

Anpath Group (OTC BB: ANPG) CEO Interview

January 15, 2010 Jack Comments Off

Anpath Group (OTC BB: ANPG) Interview with Lloyd Breedlove, CEO & President […]

Maestro Ventures (TSX.V: MAP) CEO Interview

January 15, 2010 Jack Comments Off

Maestro Ventures (TSX.V: MAP) Interview with Kris Kottmeier, CEO […]

Urigen Pharmaceuticals (OTC BB: URGP) CEO Interview

January 15, 2010 Jack Comments Off

Urigen Pharmaceuticals (OTC BB: URGP) Interview with William Garner, President & CEO […]

VitaminSpice (OTC BB: VTMS) CEO Interview

January 15, 2010 Jack Comments Off

VitaminSpice (OTC BB: VTMS) Interview with Edward Bukstel, CEO […]

Macusani Yellowcake (TSX.V: YEL) CEO Interview

January 14, 2010 Jack Comments Off

Macusani Yellowcake (TSX.V: YEL) Interview with Peter Hooper, CEO […]

AuraSource,Inc (OTC BB: ARAO) CEO Interview

January 14, 2010 Jack Comments Off

AuraSource,Inc (OTC BB: ARAO) Interview with Philip Liu, CEO […]

Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus

September 10, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities

September 10, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early

September 10, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].

September 4, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards

September 4, 2025 Comments Off on Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

August 28, 2025 Comments Off on Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X

July 23, 2025 Comments Off on Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X
Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)

June 11, 2025 Comments Off on Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)
Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

May 14, 2025 Comments Off on Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential
Next Super Stock: Snow Lake Energy (NASDAQ: LITM) “District Scale” Pine Ridge URANIUM Project

May 9, 2025 Comments Off on Next Super Stock: Snow Lake Energy (NASDAQ: LITM) “District Scale” Pine Ridge URANIUM Project

Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X

July 23, 2025 Comments Off on Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X
Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)

June 11, 2025 Comments Off on Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)
Next Super Stock Lottery.com (NASDAQ: LTRY) +10X Upside Potential Building Top Online Brands

May 23, 2025 Comments Off on Next Super Stock Lottery.com (NASDAQ: LTRY) +10X Upside Potential Building Top Online Brands
Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

May 14, 2025 Comments Off on Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

Month: January 2010

GlobalSCAPE (NYSE AMEX: GSB) CEO Interview

Intra Op Medical (OTC BB: IOPD) CEO Interview

Nemaska Exploration (TSX.V:NMX) CEO Interview

International PBX Ventures Acquires Copper/Molybdenum Mineral Claims in Chile

International PBX Ventures Ltd (TSX.V: PBX) CEO Interview

Marc Faber “Sell Your Stocks and Get Drunk in 2010”

How to Profit From the “Double Dip” Recession

2010 is “Year of Reckoning” According to Pimco’s Bill Gross

Sitebrand, Inc (TSX.V: SIB) CEO Interview

Anpath Group (OTC BB: ANPG) CEO Interview

Maestro Ventures (TSX.V: MAP) CEO Interview

Urigen Pharmaceuticals (OTC BB: URGP) CEO Interview

VitaminSpice (OTC BB: VTMS) CEO Interview

Macusani Yellowcake (TSX.V: YEL) CEO Interview

AuraSource,Inc (OTC BB: ARAO) CEO Interview

Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X

Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)

Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

Next Super Stock: Snow Lake Energy (NASDAQ: LITM) “District Scale” Pine Ridge URANIUM Project

Next Super Stock SNOW LAKE ENERGY (NASDAQ: LITM) Massive URANIUM Projects in Wyoming & Namibia